Zhao Wangfa, Bianchi Riccardo, Wang Min, Wong Robert K S
Department of Physiology and Pharmacology, State University of New York Downstate Medical Center, Brooklyn, New York 11203, USA.
J Neurosci. 2004 Jan 7;24(1):76-84. doi: 10.1523/JNEUROSCI.4515-03.2004.
Transient stimulation of group I metabotropic glutamate receptors (mGluRs) induces persistent prolonged epileptiform discharges in hippocampal slices via a protein synthesis-dependent process. At present, the signaling process underlying the induction of these epileptiform discharges remains unknown. We examined the possible role of extracellular signal-regulated kinases (ERK1 and ERK2) because these kinases can be activated by group I mGluRs, and their activation may regulate gene expression and alter protein synthesis. The group I mGluR agonist (S)-3,5-dihydroxyphenylglycine (DHPG; 50 microm) induced activation of ERK1/2 in hippocampal slices. 2-(2-Diamino-3-methoxyphenyl-4H-1-benzopyran-4-one (PD98059) (50 microm) a specific inhibitor of mitogen-activated protein kinase kinase (MEK), suppressed ERK1/2 activation by DHPG. PD98059 or another MEK inhibitor, 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene (10 microm), also prevented the induction of the prolonged epileptiform discharges by DHPG. In the presence of ionotropic glutamate receptor inhibitors and tetrodotoxin (blockers), DHPG-induced epileptiform discharges were suppressed, whereas ERK1/2 activation persisted. Protein kinase C inhibitors (2-[1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl]-3-(1H-indol-3-yl) maleimide, 1 microm; or chelerythrine, 10 microm) did not prevent the generation of DHPG-induced epileptiform discharges, nor did they suppress the activation of ERK1/2 by DHPG in slices pretreated with the blockers. Genistein (30 microm), a broad-spectrum tyrosine kinase inhibitor, suppressed the DHPG-induced epileptiform discharges and the ERK1/2 activation in the presence of blockers. Induction of DHPG-mediated epileptiform discharges was also suppressed by 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-D]pyrimidine (10 microm), an Src-family tyrosine kinase inhibitor. The study shows that group I mGluRs activate ERK1/2 through a tyrosine kinase-dependent process and that this activation of ERK1/2 is necessary for the induction of prolonged epileptiform discharges in the hippocampus.
对I组代谢型谷氨酸受体(mGluRs)的短暂刺激通过一种蛋白质合成依赖性过程在海马切片中诱导持续延长的癫痫样放电。目前,这些癫痫样放电诱导背后的信号传导过程仍不清楚。我们研究了细胞外信号调节激酶(ERK1和ERK2)的可能作用,因为这些激酶可被I组mGluRs激活,且它们的激活可能调节基因表达并改变蛋白质合成。I组mGluR激动剂(S)-3,5-二羟基苯甘氨酸(DHPG;50微摩尔)诱导海马切片中ERK1/2的激活。2-(2-二氨基-3-甲氧基苯基-4H-1-苯并吡喃-4-酮)(PD98059)(50微摩尔),一种丝裂原活化蛋白激酶激酶(MEK)的特异性抑制剂,抑制了DHPG对ERK1/2的激活。PD98059或另一种MEK抑制剂1,4-二氨基-2,3-二氰基-1,4-双[2-氨基苯硫基]丁二烯(10微摩尔)也可防止DHPG诱导延长的癫痫样放电。在离子型谷氨酸受体抑制剂和河豚毒素(阻断剂)存在的情况下,DHPG诱导的癫痫样放电受到抑制,而ERK1/2的激活持续存在。蛋白激酶C抑制剂(2-[1-(3-二甲基氨基丙基)-5-甲氧基吲哚-3-基]-3-(1H-吲哚-3-基)马来酰亚胺,1微摩尔;或白屈菜红碱,10微摩尔)既不能阻止DHPG诱导的癫痫样放电的产生,也不能抑制在经阻断剂预处理的切片中DHPG对ERK1/2的激活。广谱酪氨酸激酶抑制剂染料木黄酮(30微摩尔)在存在阻断剂的情况下抑制了DHPG诱导癫痫样放电和ERK1/2的激活。Src家族酪氨酸激酶抑制剂4-氨基-5-(4-氯苯基)-7-(叔丁基)吡唑并[3,4-D]嘧啶(10微摩尔)也抑制了DHPG介导的癫痫样放电的诱导。该研究表明,I组mGluRs通过酪氨酸激酶依赖性过程激活ERK1/2,且ERK1/2的这种激活对于海马中延长的癫痫样放电的诱导是必需的。